Hubert Schrezenmeier

The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Neal S. Young, Jörg Schubert et al. · New England Journal of Medicine · 2006 · 1.2K citations · Full text

SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies

Markus Hoffmann, Prerna Arora, Rüdiger Groß et al. · Cell · 2021 · 1K citations · Full text

Immunology, Virology, Viral Structural Protein +3

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli et al. · Blood · 2007 · 640 citations

Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria

Peter Hillmen, Petra Muus, Ulrich Dührsen et al. · Blood · 2007 · 572 citations · Full text

Cdc42 Activity Regulates Hematopoietic Stem Cell Aging and Rejuvenation

Maria Carolina Florian, Karin Dörr, Anja Niebel et al. · Cell stem cell · 2012 · 570 citations · Full text

Medicine, Stem Cell Mobilization, Stem Cell Research +4